Viemed Healthcare, Inc.
VMD
$6.88
-$0.16-2.27%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 18.90% | 17.11% | 19.97% | 22.54% | 26.22% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.90% | 17.11% | 19.97% | 22.54% | 26.22% |
| Cost of Revenue | 26.05% | 24.94% | 27.36% | 29.66% | 28.57% |
| Gross Profit | 14.18% | 12.09% | 15.26% | 18.11% | 24.73% |
| SG&A Expenses | 15.71% | 14.84% | 18.56% | 20.05% | 24.59% |
| Depreciation & Amortization | -8.45% | -15.38% | -9.58% | 6.61% | 31.39% |
| Other Operating Expenses | 54.49% | -35.19% | -1,704.65% | -641.84% | -219.27% |
| Total Operating Expenses | 20.13% | 18.86% | 21.55% | 23.44% | 25.68% |
| Operating Income | 5.04% | -2.36% | 2.25% | 12.69% | 32.70% |
| Income Before Tax | 34.29% | 49.32% | 22.20% | 12.36% | 15.83% |
| Income Tax Expenses | 35.77% | 46.02% | 24.73% | 14.78% | 21.22% |
| Earnings from Continuing Operations | 33.66% | 50.79% | 21.17% | 11.38% | 13.67% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -936.11% | -3,377.78% | -- | -- | -- |
| Net Income | 30.55% | 47.63% | 18.96% | 9.98% | 13.28% |
| EBIT | 5.04% | -2.36% | 2.25% | 12.69% | 32.70% |
| EBITDA | 7.94% | 3.35% | 6.79% | 14.66% | 26.62% |
| EPS Basic | 29.22% | 45.44% | 17.29% | 8.55% | 11.93% |
| Normalized Basic EPS | 6.56% | -0.44% | -12.03% | -1.72% | 14.49% |
| EPS Diluted | 31.42% | 52.92% | 22.49% | 14.58% | 10.09% |
| Normalized Diluted EPS | 6.34% | -0.67% | -12.13% | -1.81% | 14.69% |
| Average Basic Shares Outstanding | 1.10% | 1.53% | 1.41% | 1.32% | 1.29% |
| Average Diluted Shares Outstanding | 1.50% | 1.90% | 1.49% | 1.20% | 1.04% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |